Multimodality imaging of neoplastic and non-neoplastic solid lesions of the pancreas

Radiographics

Volumn 31, Issue 4, 2011, Pages 993-1015

  Low, Gavin ^a   Panu, Anukul ^a   Millo, Noam ^a   Leen, Edward ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC IMAGING; HUMAN; IMAGE ENHANCEMENT; IMAGE SUBTRACTION; METHODOLOGY; PANCREAS TUMOR;

DIAGNOSTIC IMAGING; HUMANS; IMAGE ENHANCEMENT; PANCREATIC NEOPLASMS; SUBTRACTION TECHNIQUE;

EID: 79960504348     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.314105731     Document Type: Article

References (67)

1. Winter JM, Cameron JL, Lillemoe KD, et al. Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann Surg 2006;243(5):673-680; discussion 680-683.
2. Ros PR, Mortelé KJ. Imaging features of pancreatic neoplasms. JBR-BTR 2001;84(6):239-249.
3. Brennan DD, Zamboni GA, Raptopoulos VD, Kruskal JB. Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT. RadioGraphics 2007;27(6): 1653-1666.
4. Tempero M, Arnoletti JP, Behrman S, et al. Clinical Practice Guidelines in Oncology: pancreatic adenocarcinoma. National Comprehensive Cancer Network. 2010; version 2. Available at: http://www.nccn.org/. Accessed July 2010.
5. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 1997;168(6):1439-1443.
6. Hough TJ, Raptopoulos V, Siewert B, Matthews JB. Teardrop superior mesenteric vein: CT sign for unresectable carcinoma of the pancreas. AJR Am J Roentgenol 1999;173(6):1509-1512.
7. Kosmahl M, Pauser U, Anlauf M, Klöppel G. Pancreatic ductal adenocarcinomas with cystic features: neither rare nor uniform. Mod Pathol 2005; 18(9):1157-1164.
8. Hanbidge AE. Cancer of the pancreas: the best image for early detection-CT, MRI, PET or US? Can J Gastroenterol 2002;16(2):101-105.
9. DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004;141(10):753-763.
10. Inokuma T, Okamoto T, Ogami T, et al. Diagnosis of pancreatic cancer with FDG-PET: comparison with CT, US and endoscopic US [abstr]. Gut 1996; 39(suppl 3):12.
11. Berberat P, Friess H, Kashiwagi M, Beger HG, Büchler MW. Diagnosis and staging of pancreatic cancer by positron emission tomography. World J Surg 1999;23(9):882-887.
12. Fröhlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN. Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 1999;40(2):250-255.
13. Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 2005; 19(5):753-781.
14. Noone TC, Hosey J, Firat Z, Semelka RC. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab 2005;19(2):195-211.
15. Gouya H, Vignaux O, Augui J, et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 2003;181(4):987-992.
16. Owen NJ, Sohaib SA, Peppercorn PD, et al. MRI of pancreatic neuroendocrine tumours. Br J Radiol 2001;74(886):968-973.
17. Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 2000; 214(2):483-490.
18. Ricke J, Klose KJ, Mignon M, Oberg K, Wiedenmann B. Standardisation of imaging in neuroendocrine tumours: results of a European delphi process. Eur J Radiol 2001;37(1):8-17.
19. Franz VK. Tumors of the pancreas. In: Atlas of tumor pathology, fasc 27-28, ser 7. Washington, DC: Armed Forces Institute of Pathology, 1959; 32-33.
20. Adams AL, Siegal GP, Jhala NC. Solid pseudopapillary tumor of the pancreas: a review of salient clinical and pathologic features. Adv Anat Pathol 2008;15(1):39-45.
21. Buetow PC, Buck JL, Pantongrag-Brown L, Beck KG, Ros PR, Adair CF. Solid and papillary epithelial neoplasm of the pancreas: imaging-pathologic correlation on 56 cases. Radiology 1996;199(3): 707-711.
22. Al-Qahtani S, Gudinchet F, Laswed T, et al. Solid pseudopapillary tumor of the pancreas in children: typical radiological findings and pathological correlation. Clin Imaging 2010;34(2):152-156.
23. Yao X, Ji Y, Zeng M, Rao S, Yang B. Solid pseudopapillary tumor of the pancreas: cross-sectional imaging and pathologic correlation. Pancreas 2010;39 (4):486-491.
24. Cantisani V, Mortele KJ, Levy A, et al. MR imaging features of solid pseudopapillary tumor of the pancreas in adult and pediatric patients. AJR Am J Roentgenol 2003;181(2):395-401.
25. Chung EM, Travis MD, Conran RM. Pancreatic tumors in children: radiologic-pathologic correlation. RadioGraphics 2006;26(4):1211-1238.
26. Sheng L, Weixia Z, Longhai Y, Jinming Y. Clinical and biologic analysis of pancreatoblastoma. Pancreas 2005;30(1):87-90.
27. Papaioannou G, Sebire NJ, McHugh K. Imaging of the unusual pediatric 'blastomas'. Cancer Imaging 2009;9:1-11.
28. Montemarano H, Lonergan GJ, Bulas DI, Selby DM. Pancreatoblastoma: imaging findings in 10 patients and review of the literature. Radiology 2000;214(2):476-482.
29. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. I. Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997;8(8):727-737.
30. Nayer H, Weir EG, Sheth S, Ali SZ. Primary pancreatic lymphomas: a cytopathologic analysis of a rare malignancy. Cancer 2004;102(5):315-321.
31. Merkle EM, Bender GN, Brambs HJ. Imaging findings in pancreatic lymphoma: differential aspects. AJR Am J Roentgenol 2000;174(3):671-675.
32. Tsitouridis I, Diamantopoulou A, Michaelides M, Arvanity M, Papaioannou S. Pancreatic metastases: CT and MRI findings. Diagn Interv Radiol 2010; 16(1):45-51.
33. Merkle EM, Boaz T, Kolokythas O, Haaga JR, Lewin JS, Brambs HJ. Metastases to the pancreas. Br J Radiol 1998;71(851):1208-1214.
34. Muranaka T, Teshima K, Honda H, Nanjo T, Hanada K, Oshiumi Y. Computed tomography and histologic appearance of pancreatic metastases from distant sources. Acta Radiol 1989;30(6):615-619.
35. Kelekis NL, Semelka RC, Siegelman ES. MRI of pancreatic metastases from renal cancer. J Comput Assist Tomogr 1996;20(2):249-253.
36. Klein KA, Stephens DH, Welch TJ. CT characteristics of metastatic disease of the pancreas. Radio- Graphics 1998;18(2):369-378.
37. Tajima Y, Kuroki T, Tsutsumi R, Isomoto I, Uetani M, Kanematsu T. Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 2007;13(6):858-865.
38. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993;328(20):1433-1437.
39. Siddiqi AJ, Miller F. Chronic pancreatitis: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR2007;28(5):384-394.
40. Ichikawa T, Sou H, Araki T, et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 2001;221(1):107-116.
41. Chang WI, Kim BJ, Lee JK, et al. The clinical and radiological characteristics of focal mass-forming autoimmune pancreatitis: comparison with chronic pancreatitis and pancreatic cancer. Pancreas 2009; 38(4):401-408.
42. Wakabayashi T, Kawaura Y, Satomura Y, et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003;98(12):2679-2687.
43. Shanbhogue AK, Fasih N, Surabhi VR, Doherty GP, Shanbhogue DK, Sethi SK. A clinical and radiologic review of uncommon types and causes of pancreatitis. RadioGraphics 2009;29(4):1003-1026.
44. Johnson PT, Outwater EK. Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology 1999;212(1):213-218.
45. Kim T, Murakami T, Takamura M, et al. Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 2001;177(2):367-371.
46. Yamada Y, Mori H, Matsumoto S, Kiyosue H, Hori Y, Hongo N. Pancreatic adenocarcinoma versus chronic pancreatitis: differentiation with triplephase helical CT. Abdom Imaging 2010;35(2): 163-171.
47. Fattahi R, Balci NC, Perman WH, et al. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging 2009;29(2):350-356.
48. Friess H, Langhans J, Ebert M, et al. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-d-glucose positron emission tomography. Gut 1995;36 (5):771-777.
49. Kawamoto S, Siegelman SS, Bluemke DA, Hruban RH, Fishman EK. Focal fatty infiltration in the head of the pancreas: evaluation with multidetector computed tomography with multiplanar reformation imaging. J Comput Assist Tomogr 2009;33(1): 90-95.
50. Kim HJ, Byun JH, Park SH, et al. Focal fatty replacement of the pancreas: usefulness of chemical shift MRI. AJR Am J Roentgenol 2007;188(2): 429-432.
51. Isserow JA, Siegelman ES, Mammone J. Focal fatty infiltration of the pancreas: MR characterization with chemical shift imaging. AJR Am J Roentgenol 1999;173(5):1263-1265.
52. Mortelé KJ, Mortelé B, Silverman SG. CT features of the accessory spleen. AJR Am J Roentgenol 2004;183(6):1653-1657.
53. Kim SH, Lee JM, Han JK, et al. Intrapancreatic accessory spleen: findings on MR imaging, CT, US and scintigraphy, and the pathologic analysis. Korean J Radiol 2008;9(2):162-174.
54. Herédia V, Altun E, Bilaj F, Ramalho M, Hyslop BW, Semelka RC. Gadolinium- and superparamagnetic- iron-oxide-enhanced MR findings of intrapancreatic accessory spleen in five patients. Magn Reson Imaging 2008;26(9):1273-1278.
55. Ross BA, Jeffrey RB Jr, Mindelzun RE. Normal variations in the lateral contour of the head and neck of the pancreas mimicking neoplasm: evaluation with dual-phase helical CT. AJR Am J Roentgenol 1996;166(4):799-801.
56. Mortelé KJ, Rocha TC, Streeter JL, Taylor AJ. Multimodality imaging of pancreatic and biliary congenital anomalies. RadioGraphics 2006;26(3): 715-731.
57. Dinter D, Löhr JM, Neff KW. Bifid tail of the pancreas: benign bifurcation anomaly. AJR Am J Roentgenol 2007;189(5):W251-W253.
58. Wijkstrom M, Bechara RI, Sarmiento JM. A rare non-malignant mass of the pancreas: case report and review of pancreatic sarcoidosis. Am Surg 2010; 76(1):79-84.
59. Soyer P, Gottlieb L, Bluemke DA, Fishman E. Sarcoidosis of the pancreas mimicking pancreatic cancer: CT features. Eur J Radiol 1994;19(1):32-33.
60. Baroni RH, Pedrosa I, Tavernaraki E, Goldsmith J, Rofsky NM. Pancreatic sarcoidosis: MRI features. J Magn Reson Imaging 2004;20(5):889-893.
61. Warshauer DM, Lee JK. Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol 2004; 182(1):15-28.
62. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956;9(4):822-830.
63. Chaulin B, Pontais C, Laurent F, De Mascarel A, Drouillard J. Pancreatic Castleman disease: CT findings. Abdom Imaging 1994;19(2):160-161.
64. Tunru-Dinh VW, Ghani A, Tom YD. Rare case of Castleman disease involving the pancreas. Am Surg 2007;73(12):1284-1287.
65. Campra D, Farina EC, Resegotti A, et al. Castleman disease in differential diagnosis of a pancreatic mass. Eur J Surg 2002;168(12):744-746.
66. Wasielica-Berger J, Kaniewska M, Cepowicz D, Wereszczynska-Siemiatkowska U, Kedra B, Dabrowski A. Castleman disease imitating pancreatic tumor presenting with pericardial and pleural effusion. Pancreas 2007;35(4):382-384.
67. Soler R, Rodríguez E, Bello MJ, Alvarez M. Pancreatic Castleman's disease: MR findings. Eur Radiol 2003;13(suppl 4):L48-L50.